(133 days)
Not Found
No
The summary describes an integrated imaging system combining existing X-ray and MRI technologies. There is no mention of AI, ML, or related concepts in the intended use, device description, or performance studies. The focus is on the physical integration and functionality of the combined modalities.
No
The device is described as an integrated imaging system for diagnostic and interventional procedures, and a magnetic resonance diagnostic device (MRDD). Its primary function is to produce images that assist in diagnosis and guide procedures, rather than directly treat a condition.
Yes
The text explicitly states that the iMRX system is designed for "diagnostic" imaging and that its components, specifically the IMRIS family of Intra-operative MRI systems, are "indicated for use as a magnetic resonance diagnostic device (MRDD)". It also mentions that the images and spectra generated by the system, when interpreted by a trained physician, "yield information that may assist in diagnosis."
No
The device description explicitly states that the iMRX system is an "integrated configuration combining X-ray Angiography and Magnetic Resonance" and includes a "traditional MRI unit that has been suspended on an overhead rail system." This clearly indicates the presence of significant hardware components, not just software.
Based on the provided information, the iMRX device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use clearly states that the iMRX system is for "interventional, diagnostic, and intra-operative imaging." It produces images of the internal structure and function of the body.
- Mechanism of Action: The device uses X-ray Angiography and Magnetic Resonance imaging modalities. These are imaging techniques that visualize structures within the body, not tests performed on samples taken from the body.
- No Mention of Samples: The description does not mention the use of any biological samples (blood, urine, tissue, etc.) which are characteristic of IVDs.
- Focus on Imaging: The entire description revolves around the acquisition, display, and interpretation of medical images.
In Vitro Diagnostics (IVDs) are devices intended for use in the examination of specimens derived from the human body in order to provide information for diagnostic purposes. The iMRX system operates by directly imaging the patient's body, not by analyzing samples from the patient.
N/A
Intended Use / Indications for Use
iMRX is an integrated imaging system combining X-ray Angiography and Magnetic Resonance for interventional, diagnostic, and intra-operative imaging.
The iMRX system uses the Artis zee family of dedicated angiography systems for single and biplane diagnostic imaging and interventional procedures including, but not limited to, pediatric and obese patients. Procedures that can be performed with the iMRX system include cardiac angiography, neuro-angiography, general angiography, rotational angiography, operating room angiography and whole body radiographic/fluoroscopic procedures. The iMRX system can also support the acquisition of position triggered imaging for spatial data synthesis.
The iMRX system uses the IMRIS family of Intra-operative MRI systems indicated for use as a magnetic resonance diagnostic device (MRDD) that produce transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and / or spectra, and that display the internal structure and / or function of the head and whole body. Depending on the region of interest, contrast agents may be used. These images and i or spectra when interpreted by a trained physician yield information that may assist in diagnosis.
The iMRX system may also be used for imaging during intra-operative and interventional procedures when performed with MR safe devices or MR conditional devices approved for use with the MR scanner.
The iMRX system may also be used for imaging in a multi-room suite.
Product codes (comma separated list FDA assigned to the subject device)
IZI, LNH
Device Description
The iMRX system is an integrated configuration combining X-ray Angiography and Magnetic Resonance for interventional, diagnostic, and intra-operative imaging. The iMRX system is the integration of a Siemens Artis zee family (biplane or floor mounted single plane) and the IMRISheuro System (Neuro III-SV or Neuro II-SE system). The iMRX system is a solution providing MRI scanning capabilities in the Angiography room while retaining all the functionality of Siemens Artis zee system. The iMRX system includes a traditional MRI unit that has been suspended on an overhead rail system, and is designed to operate inside an RF shielded room to facilitate imaging in multiple rooms. It provides imaging to support intra-operative and interventional capability in the operating room and angio room, while retaining all diagnostic functionality of a standard MRI system in the diagnostic room.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-ray Angiography, Magnetic Resonance
Anatomical Site
head and whole body
Indicated Patient Age Range
pediatric and obese patients
Intended User / Care Setting
trained physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The iMRX has been designed to provide MRI imaging in an intra-operative setting in the same manner as the predicate IMRISneuro (Neuro II-SE) Systems and to provide a complete range of angiography applications in the same manner as the predicate Siemens Arts zee system.
The iMRX system retains all Siemens Artis zee system safety features including visual and audible warnings. To minimize electrical, mechanical and radiation hazards, IMRIS adheres to recognized and established industry practice, and all equipment complies with standard performance testing. Testing has been combleted to verify the equivalence of iMRX to the Siemens Artis zee system. This assures that the performance of this device can be considered safe and effective with respect to the currently available Siemens Artis zee system.
The iMRX intra-operative features, including Siemens MRI system, Magnet Mover Assembly, OR Patient Table, Intra-operative Coils and Head Fixation Device are substantially equivalent to the same intra-operative features of the predicate Neuro III-SV and predicate Neuro II-SE. The iMRX does not raise any new safety or effectiveness issues related to the use of a moving MRI system in an intra-operative setting.
The iMRX MRI imaging system's software and hardware are substantially equivalent to the Neuro III-SV (based on the Siemens MAGNETOM Verio 3T MRI) System and the Neuro II-SE (based on the Siemens MAGNETOM Espree MRI) system. The iMRX does not raise any new safety issues related to static magnetic field effects, changing magnetic field effects, RF heating or acoustic noise or effectiveness issues related to specification volume, signal to noise, image uniformity, and geometric distortion, slice profile, thickness and gap, or high contrast spatial resolution. Testing has been completed to verify the equivalence of iMRX to the IMRISneuro (Neuro III-SV/Neuro II-SE) system. This assures that the performance of this device can be considered safe and effective with respect to the currently available IMRISneuro system.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K073290, K083137, K061916, K071099
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
510(k) Summary for iMRX system
510(k) SUMMARY FOR iMRX SYSTEM
1. GENERAL INFORMATION
IMRIS
| Establishment: | IMRIS Inc. | |
|---|---|---|
| Address: | 100-1370 Sony Place | |
| Winnipeg, Manitoba | ||
| Canada, R3T 1N5 | SEP - 2 2009 | |
| Registration Number: | 3003807210 | |
| Contact Person: | Mrs. B. Newis | |
| Quality Assurance Representative | ||
| email: bnewis@imris.com | ||
| Phone: 1-204-480-7070 ext.7043 | ||
| Fax: 1-204-480-7071 | ||
| Date of Summary Preparation: | April 15, 2009 | |
| Device Name: | iMRX | |
| Trade Name: | IMRISnv / IMRIScardio | |
| Classification Name: | Angiography X-ray system, Magnetic Resonance | |
| Diagnostic Device (MRDD) | ||
| Classification Panel: | Radiology | |
| Classification (CFR section): | 21 CFR 892.1600, 21 CFR 892.1000 | |
| Class: | Class II | |
| Product Code: | IZI (Angiography x-ray system), LNH (Magnetic Resonance | |
| Imaging System) |
2. INTENDED USE OF THE DEVICE
iMRX is an integrated imaging system combining X-ray Angiography and Magnetic Resonance for interventional, diagnostic, and intra-operative imaging.
The iMRX system uses the Artis zee family of dedicated angiography systems for single and biplane diagnostic imaging and interventional procedures including, but not limited to, pediatric and obese patients. Procedures that can be performed with the iMRX system include cardiac angiography, neuro-angiography, general angiography, rotational angiography, operating room angiography and whole body radiographic/fluoroscopic procedures. The iMRX system can also support the acquisition of position triggered imaging for spatial data synthesis.
The iMRX system uses the IMRIS family of Intra-operative MRI systems indicated for use as a magnetic resonance diagnostic device (MRDD) that produce transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and / or spectra, and that display the internal structure and / or function of the head and whole body. Depending on the region of interest, contrast agents may be used. These images and i or spectra when interpreted by a trained physician yield information that may assist in diagnosis.
The iMRX system may also be used for imaging during intra-operative and interventional procedures when performed with MR safe devices or MR conditional devices approved for use with the MR scanner.
The iMRX system may also be used for imaging in a multi-room suite.
1
3. INDICATIONS FOR USE
The iMRX system is indicated for use for the head and whole body.
4. DEVICE DESCRIPTION
The iMRX system is an integrated configuration combining X-ray Angiography and Magnetic Resonance for interventional, diagnostic, and intra-operative imaging. The iMRX system is the integration of a Siemens Artis zee family (biplane or floor mounted single plane) and the IMRISheuro System (Neuro III-SV or Neuro II-SE system). The iMRX system is a solution providing MRI scanning capabilities in the Angiography room while retaining all the functionality of Siemens Artis zee system. The iMRX system includes a traditional MRI unit that has been suspended on an overhead rail system, and is designed to operate inside an RF shielded room to facilitate imaging in multiple rooms. It provides imaging to support intra-operative and interventional capability in the operating room and angio room, while retaining all diagnostic functionality of a standard MRI system in the diagnostic room.
5. SUBSTANTIALLY EQUIVALENT
The iMRX system is substantially equivalent to the following cleared medical devices.
| Predicate Device name | 510(k) Number | FDA Clearance date |
|---|---|---|
| Siemens Artis zee / zeego | K073290 | Feb 11, 2008 |
| IMRIS Neuro III-SV Intra-operative MRI System | K083137 | Dec 16, 2008 |
| IMRIS Neuro II-SE Intra-operative MRI System | K061916 | |
| K071099 | Aug 11, 2006 | |
| May 22, 2007 |
6. SAFETY & EFFECTIVENESS
The iMRX has been designed to provide MRI imaging in an intra-operative setting in the same manner as the predicate IMRISneuro (Neuro II-SE) Systems and to provide a complete range of angiography applications in the same manner as the predicate Siemens Arts zee system.
The iMRX system retains all Siemens Artis zee system safety features including visual and audible warnings. To minimize electrical, mechanical and radiation hazards, IMRIS adheres to recognized and established industry practice, and all equipment complies with standard performance testing. Testing has been combleted to verify the equivalence of iMRX to the Siemens Artis zee system. This assures that the performance of this device can be considered safe and effective with respect to the currently available Siemens Artis zee system.
The iMRX intra-operative features, including Siemens MRI system, Magnet Mover Assembly, OR Patient Table, Intra-operative Coils and Head Fixation Device are substantially equivalent to the same intra-operative features of the predicate Neuro III-SV and predicate Neuro II-SE. The iMRX does not raise any new safety or effectiveness issues related to the use of a moving MRI system in an intra-operative setting.
The iMRX MRI imaging system's software and hardware are substantially equivalent to the Neuro III-SV (based on the Siemens MAGNETOM Verio 3T MRI) System and the Neuro II-SE (based on the Siemens MAGNETOM Espree MRI) system. The iMRX does not raise any new safety issues related to static magnetic field effects, changing magnetic field effects, RF heating or acoustic noise or effectiveness issues related to specification volume, signal to noise, image uniformity, and geometric distortion, slice profile, thickness and gap, or high contrast spatial resolution. Testing has been completed to verify the equivalence of iMRX to the IMRISneuro (Neuro III-SV/Neuro II-SE) system. This assures that the performance of this device can be considered safe and effective with respect to the currently available IMRISneuro system.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle in flight, rendered in blue. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle.
NOV 22 2009
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
IMRIS, Inc. % Mr. Thomas M. Tsakeris President Devices & Diagnostic Consulting Group, Inc. 16809 Briardale Road ROCKVILLE MD 20855
Re: K091166
Trade/Device Name: iMRX Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: LNH and IZI Dated: August 6, 2009 Received: August 10, 2009
Dear Mr. Tsakeris:
This letter corrects our substantially equivalent letter of September 2, 2009.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
3
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (2) CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 100-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRH0ff CF CFR Part 801), please
the Center for Devices and Podic locked on infrices/CDRH/CDRHOffices/ucm11 15809.htm fo the Center for Devices and Radiological Health 's (CDRH) incessurem i 13809.htm for the note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Pat 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrisms.net/member for the MDR regil Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll the (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Lamme M. Morsul
Janine M. Morsul
Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use Statement
510(k) Number (if known):
Device Name:
K091166
iMRX
Indications For Use:
iMRX is an integrated imaging system combining X-ray Angiography and Magnetic Resonance for interventional, diagnostic, and intra-operative imaging.
The iMRX system uses the Artis zee family of dedicated angiography systems for single and biplane diagnostic imaging that were were including, but not limited to, pediatric and obese patients. Procedures that can be performed with the MRX system include cardiac angiography, newnangiography, general angiography, rotational angiography, operating room angiography, neuro, body radiographic fluoroscopic procedures. The iMRX system can also support the acquisition of position triggered imaging for spatial data synthesis.
The iMRX system uses the IMRIS family of Intra-operative MRI systems indicated for use as a magnetic resonance diagnostic device (MRDD) that produce transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and for spectra, and that display the internal structure and / or function of the head and whole body. Depending on the region of interest, contrast agents may be used. These images and / or spectra when interpreted by a trained physician yield information that may assist in diagnosis.
The iMRX system may also be used for imaging during intra-operative and interventional procedures when performed with MR safe devices or MR conditional devices approved for use with the MR scanner.
The iMRX system may also be used for imaging in a multi-room suite.
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (Part 21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devic
510(k) Number K091166
AND/OR